XML 31 R19.htm IDEA: XBRL DOCUMENT v3.25.3
Common Stock
9 Months Ended
Sep. 30, 2025
Stockholders' Equity Note [Abstract]  
Common Stock Common Stock        
As of September 30, 2025 and December 31, 2024, there were 44,764,843 and 45,810,125 shares of our common stock outstanding, respectively.
During the three months ended September 30, 2025 and 2024, we issued 2,067 and 1,190 shares of common stock, respectively. During the nine months ended September 30, 2025 and 2024, we issued 59,448 and 81,769 shares of common stock, respectively. These shares were issued upon the satisfaction of required conditions under our share-based compensation plans.
We have paid quarterly dividends since October 25, 2011. We currently pay a regular quarterly dividend of $0.25 per share.
In September 2011, our Board of Directors (the “Board”) authorized a share repurchase program allowing us to begin repurchasing shares of our outstanding common stock. Subsequently, the Board has from time to time increased the amount authorized for repurchases under such program. In February 2025, our Board increased such amount by $500 million. Since the inception of the repurchase program, through September 30, 2025, the Board has authorized us to repurchase up to $3.15 billion of our outstanding common stock. During the nine months ended September 30, 2025, we repurchased approximately 1.1 million shares of our common stock for approximately $423.3 million, inclusive of the applicable excise tax. Since the inception of the repurchase program through September 30, 2025, we have repurchased approximately 28.2 million shares of our common stock for approximately $2.81 billion. As of September 30, 2025, there remained authorization for us to repurchase approximately $336.2 million of our shares. The repurchase program has no expiration date, does not obligate the Company to acquire any particular amount of common stock, and may be suspended, recommenced, or discontinued at any time or from time to time without prior notice. We may repurchase our shares from time to time to the extent permitted by securities laws and other legal requirements, including provisions in our 2023 Credit Agreement placing limitations on such repurchases.